NuCana (NCNA) Insider Elliott Levy Sells 23,811,896 Shares
Elliott Levy recently sold shares of NCNA, with the stock trading at $1.73.
Reviewed by automated data checks against the source filing. How we make and check alerts
Elliott Levy sold 23,811,896 shares of NuCana plc ($NCNA) on June 19, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $NCNA is down 18.9% after 1 week, down 31.4% after 1 month and down 48.2% to date (from the $1.91 close on Jun 18, 2026).
NCNA
NuCana plc
Key Points
- Elliott Levy sold shares of NCNA on June 19, 2026, with shares trading at $1.73 on Wednesday.
- NCNA has seen recent activity from peers like Citadel Advisors and Jane Street Group adjusting their positions.
- Oppenheimer maintained a buy rating on NCNA with a $150 price target as of July 22, 2024.
Get $NCNA trade alerts by text
We text you when insiders, Congress or big funds trade $NCNA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated NuCana plc alert may contain errors. Disclosures
Elliott Levy sold shares of NCNA on June 19, 2026. The stock was trading at $1.73 on Wednesday. This insider transaction wasn't part of a pre-planned trading program.
Other Institutional Activity in NCNA
Several institutional investors have recently adjusted their holdings in NCNA. Citadel Advisors LLC opened a new position, acquiring 13,855 shares valued at about $19,536. Similarly, Virtu Financial LLC also initiated a stake with 13,433 shares worth approximately $19,000. Meanwhile, Jane Street Group, LLC reduced its holdings by 819 shares, bringing its total to 10,511 shares valued at around $14,715, marking a 7.2% decrease. Rhumbline Advisers also trimmed its position by 1,187 shares, ending with 3,722 shares worth about $5,245, a 24.2% decrease.
NuCana plc Stock Up 29.1%
Shares of NCNA traded near $1.73 on Wednesday. The stock has seen varied activity from institutional investors, reflecting a dynamic market environment. As of now, detailed financial metrics like market cap and P/E ratio are not available.
Insider Buying and Selling at NuCana plc
On June 19, 2026, Elliott Levy sold shares of NCNA. On the same day, Jeffrey Bloss, Chief Medical Officer, also sold shares. Earlier, on April 15, 2026, Theresa Margaret Bruce, the Chief Operating Officer, bought shares, indicating diverse trading activities among company insiders.
Analysts Set New Price Targets
On July 22, 2024, Oppenheimer maintained a buy rating on NCNA, setting a price target of $150. This reflects the firm's positive outlook on the stock.
Bottom Line
Insider transactions like those by Elliott Levy provide insight into company dynamics, though they don't necessarily signal market direction. Institutional investors have shown varied interest in NCNA, with some opening new positions while others reduce their holdings. Analyst opinions, such as Oppenheimer's maintained buy rating, offer additional perspectives on the stock's potential. Remember, 13F filings and insider trades are backward-looking and may not reflect current positions.
Related Filing Alerts
Source: Elliott Levy's Form 4 filing on $NCNA (Jun 19, 2026). Find the original filing: NCNA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts